IRX Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:IRX Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10786
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥73,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IRX Therapeutics Inc (IRX Therapeutics) is a clinical-stage bioresearch company that develops immunotherapies which reduces the immune suppression. The company provides product that overcomes cancer induced immune suppression and restores anti-tumor response. It offers product IRX-2 which is a primary cell-derived from active cytokine components that acts on various cell types of the immune system such as T-cells, dendritic cells and natural killer cells. The company’s therapies targets and restores the immune system to improve patient’s response to next-generation cancer vaccines and novel targeted therapeutics. IRX Therapeutics is headquartered in New York, the US.

IRX Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IRX Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IRX Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
IRX Therapeutics Raises Additional USD20 Million in Venture Financing 11
IRX Therapeutics Raises USD13.2 Million in Venture Financing 12
IRX Therapeutics Raises USD6.4 Million in Venture Financing 13
IRX Therapeutics Raises USD2 Million Financing 14
IRX Therapeutics Raises USD40.58 Million in Financing Round 15
IRX Therapeutics Raises USD31.6 Million in Venture financing 16
IRX Therapeutics Raises US$15 Million In Venture Financing 17
IRX Therapeutics Raises US$1.5 Million In Venture Financing 18
Partnerships 19
IRX Therapeutics Enters into Agreement with ImmunID 19
Acquisition 20
Brooklyn ImmunoTherapeutics Acquires IRX Therapeutics 20
IRX Therapeutics Inc – Key Competitors 21
IRX Therapeutics Inc – Key Employees 22
IRX Therapeutics Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IRX Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IRX Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
IRX Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IRX Therapeutics Raises Additional USD20 Million in Venture Financing 11
IRX Therapeutics Raises USD13.2 Million in Venture Financing 12
IRX Therapeutics Raises USD6.4 Million in Venture Financing 13
IRX Therapeutics Raises USD2 Million Financing 14
IRX Therapeutics Raises USD40.58 Million in Financing Round 15
IRX Therapeutics Raises USD31.6 Million in Venture financing 16
IRX Therapeutics Raises US$15 Million In Venture Financing 17
IRX Therapeutics Raises US$1.5 Million In Venture Financing 18
IRX Therapeutics Enters into Agreement with ImmunID 19
Brooklyn ImmunoTherapeutics Acquires IRX Therapeutics 20
IRX Therapeutics Inc, Key Competitors 21
IRX Therapeutics Inc, Key Employees 22
IRX Therapeutics Inc, Other Locations 23

List of Figures
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IRX Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IRX Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[IRX Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rangeland Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Rangeland Energy LLC (Rangeland Energy) is a midstream energy company. The company services include transloading, storing frac sand, moving inbound and outbound crude oil and associated natural gas products. It also provides Rangeland integrated oil systems, which is a multipart crude and sa …
  • Tailored Brands, Inc.:企業の戦略・SWOT・財務情報
    Tailored Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tailored Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • POSCO:企業のM&A・事業提携・投資動向
    POSCO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's POSCO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisin …
  • Ansaldo Thomassen B.V.:企業の戦略的SWOT分析
    Ansaldo Thomassen B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Koch Membrane Systems Inc:企業の戦略的SWOT分析
    Koch Membrane Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Insulet Corp (PODD):製薬・医療:M&Aディール及び事業提携情報
    Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetic s. Omnipod system consists of a dispos …
  • Tobu Railway Co Ltd:戦略・SWOT・企業財務分析
    Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • DiamondRock Hospitality Co:企業のM&A・事業提携・投資動向
    DiamondRock Hospitality Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DiamondRock Hospitality Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Sanchez Energy Corp (SN):企業の財務・戦略的SWOT分析
    Summary Sanchez Energy Corp (Sanchez) is an independent exploration and production company that acquires and develops unconventional oil and natural gas resources. It operates in the horizontal development of resources from the Eagle Ford Shale in South Texas. The company also holds an undeveloped a …
  • BioSolar Inc (BSRC):企業の財務・戦略的SWOT分析
    Summary BioSolar Inc (BioSolar) is an alternative energy technology company that develops storage capacity products. The company develops technology to produce bio-based materials from renewable sources. BioSolar products include biosolar back-sheets, biosolar thin film substrate, biosolar super-str …
  • Alabama Municipal Electric Authority:企業の戦略的SWOT分析
    Alabama Municipal Electric Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Laborie Medical Technologies Inc:企業の製品パイプライン分析2018
    Summary Laborie Medical Technologies Inc (Laborie), a subsidiary of Patricia Industries AB, develops and manufactures medical diagnostics and devices. The company offers uroflowmetry, urodynamics, pelvic floor rehabilitation and anorectal manometry products and related consumables. It also provides …
  • Laing O’Rourke Australia Pty Ltd:企業の戦略的SWOT分析
    Laing O'Rourke Australia Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析
    Summary MiMedx Group Inc (MiMedx) develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Icelandair Group:戦略・SWOT・企業財務分析
    Icelandair Group - Strategy, SWOT and Corporate Finance Report Summary Icelandair Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dot Foods, Inc.:企業の戦略・SWOT・財務分析
    Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Armune BioScience Inc:医療機器:M&Aディール及び事業提携情報
    Summary Armune BioScience Inc (Armune BioScience), a subsidiary of Exact Sciences Corp is a medical device development company that develops and commercializes molecular prognostic and diagnostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or prote …
  • Mace Group Ltd:企業の戦略・SWOT・財務情報
    Mace Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Mace Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Alpiq Holding AG (ALPH)-エネルギー分野:企業M&A・提携分析
    Summary Alpiq Holding AG (Alpiq) is an independent energy services company. The company produces electricity; and carries out energy trading and energy sales. It generates energy from hydro, nuclear, coal, natural gas, wind, and solar sources. Alpiq offers energy services for buildings and plants, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆